-
Product Insights
![]()
Stanford Univ – Portola Terrace Housing – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Stanford Univ - Portola Terrace Housing - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Company Profile
![]()
Portola Pharmaceuticals LLC – Company Profile
Portola Pharmaceuticals LLC (Portola Pharmaceuticals) is a biopharmaceutical company that discovers, and develops therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. The company's products portfolio include Betrixaban, an oral once-daily Factor Xa inhibitor anticoagulant that inhibits the activity of Factor Xa, andexanet alfa, a recombinant protein designed to reverse anticoagulant activity of both direct and indirect Factor Xa inhibitors, and cerdulatinib, an oral, dual Syk-JAK inhibitor in development to treat hematologic cancers. Portola Pharmaceuticals provides compounds using...
Add to Basket -
Sector Analysis
![]()
Contract Manufacturing Service Agreements – Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion
This report is a brand new publication covering contract service agreements, across a range of different services and manufacturing scales. The number of contract service agreements secured serves as a primary indicator of a CMO's performance. Contract Manufacturing Service Agreements is critical for establishing an understanding of the overall CMO industry, the range of services provided and the features of some of the largest CMOs participating in the industry.
-
Sector Analysis
![]()
United States Advanced Wound Management Market Outlook to 2025
GlobalData’s “United States Advanced Wound Management Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Advanced Wound Management market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Alginates, Collagens, Foams, Hydrocolloids, Hydrofibres, Hydrogels, Semi-Permeable Films, Superabsorbents and Wound Contact Layers. The United States Advanced Wound Management Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices...
-
Sector Analysis
![]()
North America Advanced Wound Management Market Outlook to 2025
GlobalData’s “North America Advanced Wound Management Market Outlook to 2025” is a comprehensive databook report, covering key market data on the North America Advanced Wound Management market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Alginates, Collagens, Foams, Hydrocolloids, Hydrofibres, Hydrogels, Semi-Permeable Films, Superabsorbents and Wound Contact Layers. The North America Advanced Wound Management Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices...
-
Sector Analysis
![]()
PharmaPoint: Venous Thromboembolism – Global Drug Forecast and Market Analysis to 2025
Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from pulmonary embolism (PE) to deep vein thrombosis (DVT. The condition is relatively prevalent and is associated with long-term mortality and morbidity. VTE occurs when a thrombus (blood clot) forms in an individual's deep vein, owing to either changes in the components of their blood, damage to the endothelium in the vasculature, and/or changes in the flow of blood). When a thrombus materializes in the veins...
-
Sector Analysis
![]()
PharmaPoint: Atrial Fibrillation – Global Drug Forecast and Market Analysis to 2025
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregular and often abnormally fast heart rate. Various therapeutic options are available to treat patients with AF, and most patients will receive some form of antithrombotic therapy, a heart rate control agent, and potentially an antiarrhythmic drug for rhythm control. All sectors of the AF market have historically been saturated with generics, with the vitamin K antagonists such as warfarin playing an important...
-
Product Insights
![]()
Venous Thromboembolism Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H2, 2016" provides an overview of Venous Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials on Venous Thromboembolism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
![]()
PharmaPoint: Venous Thromboembolism – Global Drug Forecast and Market Analysis to 2026
Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from pulmonary embolism (PE) to deep vein thrombosis (DVT. The condition is relatively prevalent and is associated with long-term mortality and morbidity. VTE occurs when a thrombus (blood clot) forms in an individual’s deep vein, owing to either changes in the components of their blood, damage to the endothelium in the vasculature, and/or changes in the flow of blood). When a thrombus materializes in the veins...
-
Product Insights
![]()
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
![]()
Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Diffuse Large B-Cell Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
![]()
Venous Thromboembolism Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H2, 2018" provides an overview of Venous Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials on Venous Thromboembolism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Track & Monitor
![]()
Monthly Mining Industry Deals Review – August 2018
GlobalData's “Monthly Mining Industry Deals Review – August 2018” report is an essential source of data and trend analysis on M&A (mergers, acquisitions, and asset transactions), in the mining industry. The report provides detailed comparative monthly data on the number of deals and their value, sub-divided into deal types, by status, by region, and country. The report also highlights top buyers and sellers by region in addition to top announced and completed deals by value globally.
-
Product Insights
![]()
Atrial Flutter Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H2, 2018" provides an overview of Atrial Flutter clinical trials scenario. This report provides top line data relating to the clinical trials on Atrial Flutter. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
![]()
Chronic Lymphocytic Leukemia: Opportunity Analysis and Forecasts to 2027
Chronic lymphocytic leukemia (CLL) is a form of cancer that originates from lymphocytes in the bone marrow and later invades the blood and/or lymphoid tissues. CLL treatment has been transformed since the novel oral targeted agents Imbruvica (ibrutinib), Zydelig (idelalisib), and Venclexta (venetoclax) were introduced to the market from 2014 onwards and challenged the prior dominance of chemoimmunotherapy regimens. During the forecast period, the global CLL market will welcome five new drugs—Calquence (acalabrutinib), zanubrutinib, umbralisib, ublituximab, and Revlimid (lenalidomide). The...
-
Product Insights
![]()
Venous Thromboembolism Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2020" provides an overview of Venous Thromboembolism Clinical trials scenario. This report provides top line data relating to the clinical trials on Venous Thromboembolism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
![]()
United States Dental Devices Market Outlook to 2025 – CAD/CAM Systems and Materials, Dental Bone Graft Substitutes & Regenerative Materials, Dental Equipment and Others
“What is covered in the report about the “United States Dental Devices Market”? GlobalData’s “United States Dental Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Dental Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – CAD/CAM Systems and Materials, Dental Bone Graft Substitutes & Regenerative Materials, Dental Equipment, Dental Hygiene Devices, Dental Imaging, Dental Implants & Abutments, Dental Lasers, Dental...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.